Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Vyera Pharmaceuticals, LLC and Phoenixus AG
Penalty: $40,000,000
Year: 2021
Date: December 7, 2021
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Mega-Scandal: Drug Pricing Abuses
Violation Description: Vyera and Phoenixus agreed to pay $40 million in a settlement with several states and the FTC of allegations Vyera illegally protected the monopolistic pricing of the drug Daraprim.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.